Clinical Studies on Itraconazole

Koji Takaki, Yoshiro Sawae, Kaoru Okada, Nobuyuki Shimono, Hiroyasu Misumi

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


We performed clinical studies on itraconazole, a new triazole antifungal agent. Four patients suffering from candidemia, pulmonary aspergillosis, oral thrush, and urinary tract infection due to Trichosporon cutaneum were treated with itraconazole at a single daily dose of 100-200 mg for 9-31 days. Clinical response was good in all patients. Bacteriological effect was eradicated in 2 cases, diminished in one and unknown in one. No side effect was observed and there were no abnormal laboratory findings. A suspected case of pulmonary cryptococcosis tolerated long-term administration of itraconazole at a daily dose of 100-150 mg for 198 days without observable adverse reactions.

Original languageEnglish
Pages (from-to)273-278
Number of pages6
JournalNippon Ishinkin Gakkai Zasshi
Issue number4
Publication statusPublished - 1991

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Infectious Diseases


Dive into the research topics of 'Clinical Studies on Itraconazole'. Together they form a unique fingerprint.

Cite this